These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11585972)

  • 21. Surgical treatment for locally advanced lower third rectal cancer after neoadjuvent chemoradiation with capecitabine: prospective phase II trial.
    Elwanis MA; Maximous DW; Elsayed MI; Mikhail NN
    World J Surg Oncol; 2009 Jun; 7():52. PubMed ID: 19508705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies].
    Créhange G; Bosset JF; Maingon P
    Cancer Radiother; 2011 Oct; 15(6-7):440-4. PubMed ID: 21802334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of protracted infusion 5-fluorouracil and capecitabine in adjuvant chemoradiotherapy for rectal cancer.
    Kurt M; Ozkan L; Kurt E; Cetintas SK; Aygun S; Ercan I; Yilmazlar T; Memik F
    Hepatogastroenterology; 2008; 55(85):1158-63. PubMed ID: 18795649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemoradiation for rectal cancer: is more better?
    Patel A; Puthillath A; Yang G; Fakih MG
    Oncology (Williston Park); 2008 Jun; 22(7):814-26; discussion 826, 828-31, 836. PubMed ID: 18619122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cetuximab and chemoradiation for rectal cancer--is the water getting muddy?
    Glynne-Jones R; Mawdsley S; Harrison M
    Acta Oncol; 2010 Apr; 49(3):278-86. PubMed ID: 20180626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancer.
    Boskos CS; Liacos C; Korkolis D; Aygerinos K; Lamproglou I; Terpos E; Stoupa E; Baltatzis G; Beroukas K; Papasavvas P; Dimopoulos MA; Bamias A
    J Surg Oncol; 2010 Oct; 102(5):408-12. PubMed ID: 19877119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of preoperative irradiation and chemotherapy with capecitabine in patients with locally advanced rectal carcinoma.
    Lay GC; Caraul B; Dessì M; Orrù S; Murtas R; Deidda MA; Farigu R; Farci D; Maxia L; Casula G; Amichetti M
    J Exp Clin Cancer Res; 2007 Mar; 26(1):61-70. PubMed ID: 17550133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current options for the management of rectal cancer.
    O'Neil BH; Tepper JE
    Curr Treat Options Oncol; 2007 Oct; 8(5):331-8. PubMed ID: 18181024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of preoperative radiochemotherapy with capecitabine for resectable locally advanced rectal cancer in elderly patients.
    Ausili Cèfaro G; Genovesi D; Vinciguerra A; Augurio A; Di Tommaso M; Marchese R; Borzillo V; Tasciotti L; Taraborrelli M; Innocenti P; Colecchia G; Di Nicola M
    Tumori; 2012; 98(5):622-9. PubMed ID: 23235758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer.
    Park JH; Yoon SM; Yu CS; Kim JH; Kim TW; Kim JC
    Cancer; 2011 Aug; 117(16):3703-12. PubMed ID: 21328328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer].
    Jin J; Li YX; Liu YP; Wang WH; Li T; Li N; Song YW
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):393-6. PubMed ID: 17045010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response.
    Balboa E; Duran G; Lamas MJ; Gomez-Caamaño A; Celeiro-Muñoz C; Lopez R; Carracedo A; Barros F
    Pharmacogenomics; 2010 Jun; 11(6):747-61. PubMed ID: 20504250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-operative chemoradiotherapy with oral capecitabine in locally advanced, resectable rectal cancer.
    Korkolis DP; Boskos CS; Plataniotis GD; Gontikakis E; Karaitianos IJ; Avgerinos K; Katopodi A; Xinopoulos D; Dimitroulopoulos D; Beroukas K; Vassilopoulos PP
    Anticancer Res; 2007; 27(1B):541-5. PubMed ID: 17348439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of 5-fluorouracil-based chemoradiation in the management of rectal cancer.
    Patel PA
    Anticancer Drugs; 2011 Apr; 22(4):311-6. PubMed ID: 21301320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study.
    De Paoli A; Chiara S; Luppi G; Friso ML; Beretta GD; Del Prete S; Pasetto L; Santantonio M; Sarti E; Mantello G; Innocente R; Frustaci S; Corvò R; Rosso R
    Ann Oncol; 2006 Feb; 17(2):246-51. PubMed ID: 16282246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.
    Fernández-Martos C; Pericay C; Aparicio J; Salud A; Safont M; Massuti B; Vera R; Escudero P; Maurel J; Marcuello E; Mengual JL; Saigi E; Estevan R; Mira M; Polo S; Hernandez A; Gallen M; Arias F; Serra J; Alonso V
    J Clin Oncol; 2010 Feb; 28(5):859-65. PubMed ID: 20065174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review.
    Saif MW; Hashmi S; Zelterman D; Almhanna K; Kim R
    Int J Colorectal Dis; 2008 Feb; 23(2):139-45. PubMed ID: 17909820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes.
    Gollins S; Sun Myint A; Haylock B; Wise M; Saunders M; Neupane R; Essapen S; Samuel L; Dougal M; Lloyd A; Morris J; Topham C; Susnerwala S
    J Clin Oncol; 2011 Mar; 29(8):1042-9. PubMed ID: 21263095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative concomitant radiotherapy with oral capecitabine in advanced rectal cancer within 6 cm from anal verge.
    Elshazly WG; Farouk M; Samy M
    Int J Colorectal Dis; 2009 Apr; 24(4):401-7. PubMed ID: 19084971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal time interval between capecitabine intake and radiotherapy in preoperative chemoradiation for locally advanced rectal cancer.
    Yu CS; Kim TW; Kim JH; Choi WS; Kim HC; Chang HM; Ryu MH; Jang SJ; Ahn SD; Lee SW; Shin SS; Choi EK; Kim JC
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1020-6. PubMed ID: 17197127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.